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Two-Step Polymerase Chain Reactions and Restriction
Endonuclease Analyses Detect and Differentiate ompA DNA
of Chlamydia spp.
BERNHARD KALTENBOECK,t KONSTANTIN G. KOUSOULAS,

AND JOHANNES

STORZ*

Department of Veterinary Microbiology and Parasitology, School of Veterinary Medicine, Louisiana State University,
Baton Rouge, Louisiana 70803

Specific and sensitive amplification of major outer membrane protein (MOMP) gene (ompA) DNA sequences
of Chlamydia species with various MOMP genotypes was achieved by a two-step polymerase chain reaction
(PCR). Degenerate, inosine-containing oligonucleotide primers homologous to the 5' and 3' ends of the
translated regions of all chlamydial MOMP genes were used in a PCR to amplify a DNA fragment of
approximately 1,120 bp. A portion of this DNA fragment was amplified in a second genus-specific reaction that
yielded a DNA fragment of approximately 930 bp. A pair of degenerate oligonucleotide primers homologous to
internal sequences of the primary DNA fragment was used in this PCR. This method detected three cognate
chlamydial genomes in a background of 1 ,ug of unrelated DNA. MOMP genes of 13 representative chlamydial
MOMP genotypes of the species C. trachomatis, C. pneumoniae, and C. psittaci were amplified. In a secondary
PCR, group-specific detection was achieved by the simultaneous use of one genus-specific primer and three
primers derived from different fingerprint regions of three major groups of chlamydiae. This multiplex PCR
differentiated the groups by the length of the amplified DNA fragments and detected the simultaneous presence
of DNA sequences of the Chiamydia spp. with different MOMP genotypes. Further differentiation as ompA
restriction fragment length polymorphism types among all chlamydial strains with the various MOMP
genotypes analyzed here was achieved by restriction endonuclease analysis of the secondary PCR products.
DNA sequences corresponding to the ompA restriction fragment length polymorphism type B577 of C. psittaci
were detected in two of seven milk samples from cases of bovine mastitis.

mydiae were analyzed (12). Four groups of MOMP genotypes were found. C. trachomatis with the porcine chlamydial isolate S45 made up the trachoma group. C. pneumoniae
combined with the MOMP genotype KOALA of isolates
from the koala (Phascolarctos cinereus) formed the pneumonia group. A cluster of C. psittaci strains from ruminant
and porcine hosts with a propensity for causing polyarthritispolyserositis was termed the polyarthritis group. Strains of
C. psittaci originating from avian, human, ruminant, feline,
and guinea pig hosts made up the psittacosis group.
On the basis of these findings, we explored the possibility
of sensitive genus-specific detection of Chlamydia spp. by
PCR. We report here the detection of Chlamydia spp. by
PCR amplification of MOMP gene DNA sequences, the
PCR-based classification of chlamydial MOMP genes into
four major groups, the differentiation of ompA restriction
fragment length polymorphism (RFLP) types within these
groups by restriction endonuclease analysis, and the detection of C. psittaci in clinical specimens.
(This report contains parts of a dissertation presented by
B. Kaltenboeck to the Graduate School of Louisiana State
University in partial fulfillment of the requirements for the
Ph.D. degree.)

Chlamydiae are widespread intracellular bacteria that
cause clinically inapparent infections and a variety of diseases in humans, marsupials, other mammals, and birds. In
humans, the most notable diseases are trachoma and urogenital infections caused by C. trachomatis, respiratory
infections caused by C. pneumoniae, and psittacosis caused
by C. psittaci (9, 22). In animals, C. psittaci is capable of
inducing diverse disease syndromes like enteritis, urogenital
infections and abortions, pneumonia, polyarthritis, polyserositis, encephalitis, and mastitis (25).
These agents are detected by cell culture isolation, enzyme-linked immunosorbent assay methods for chlamydial
antigen identification, and in situ hybridization (23). Recently, sensitive polymerase chain reaction (PCR) methods
were reported for the detection of DNA sequences of the
common plasmid of C. trachomatis (5, 19) and the major
outer membrane protein (MOMP) genes of C. trachomatis,
C. pneumoniae, and C. psittaci (10). While the species C.
trachomatis and C. pneumoniae were examined comprehensively (10), amplification of the highly heterogeneous species
C. psittaci was analyzed by using only one representative
strain. Thus, it is uncertain which variants of C. psittaci can
be detected by PCR.
Recently, we obtained partial (81%) MOMP gene DNA
sequences of 25 representative chlamydial strains using
PCR. On the basis of the sequences of the ompA loci from
different strains, phylogenetic relationships among the chla*

MATERIALS AND METHODS
Chlamydial strains. Thirteen strains of Chlamydia representing 13 MOMP genotypes; at least nine serovars; and six
genomic RFLP types of human, koala, bovine, ovine, porcine, feline, guinea pig, and murine origin (7, 12, 20) were
used in this investigation. Relevant information about the
isolates is summarized in Table 1. All chlamydial strains
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TABLE 1. Origin, MOMP genotype, serovar, and RFLP type of chlamydial strains included in detection and differentiation of
chiamydial MOMP genes by PCR
Chlamydial strain

MOMP genotype"

Serovar*

C. pneumoniae AR388

AR388

C. psittaci
KOALA
FEPN
GPIC
B577
BMZ1121

KOALA
FEPN
GPIC
B577
MN

7
8
1

MOPN
L2
S45

L2
5

66P130
LW613
L71
1710S

3
2
4
6

C. trachomatis
MOPN
L2
S45

RFLP type'

Host

Host clinical condition

Reference

Human

Respiratory infection

3

Koala
Cat
Guinea pig
Sheep
Cattle

Keratoconjunctivitis
Live vaccine
Conjunctivitis
Abortion
Mastitis

8
20
20
20
14

Mouse
Human

Mouse
Human
Swine

Pneumonia
Lymphogranuloma venereum
Inapparent intestinal infection

18
26
20

Ruminant 1

Cattle
Cattle
Swine
Swine

Inapparent intestinal infection
Polyarthritis
Polyarthritis
Abortion

20
20
20
20

Feline 1
Avian 2b
Avian lb

C. psittaci
66P130
LW613
L71
1710S

except C. pneumoniae AR388 and C. psittaci KOALA were
propagated in developing chicken embryos as described
previously (20). In addition, strain B577 was also cultivated
in persistently infected L cells (21).
Extraction of chlamydial DNA. Heavily infected yolk sacs
and purified B577 elementary bodies were used for the
isolation of chlamydial DNA by cetyltrimethylammonium
bromide extraction as described previously (13). Purified
DNAs from C. pneumoniae AR388 and C. psittaci KOALA
were kind gifts of L. A. Campbell, University of Washington, Seattle, and Adeeb A. Girjes, University of Queensland, Brisbane, Queensland, Australia, respectively.
Chlamydia-negative background DNAs from uninfected L
cells and bacteria likely to be encountered in clinical specimens (Eschenichia coli, Salmonella cholerae-suis, Bordetella bronchiseptica, Pseudomonas aeruginosa) were extracted after low-speed sedimentation as described
previously (13).
Oligonucleotide primers. A schematic representation of the

chlamydial MOMP gene (now termed ompA [27]), the relative locations of the primers, and the DNA fragments
generated in the PCRs are presented in Fig. 1. The primers
are described in Table 2. These degenerate, inosine-containing oligonucleotide primers (17) were synthesized in our
laboratory by the phosphoramidite method on a Gene Assembler Plus Synthesizer (Pharmacia-LKB, Piscataway,
N.J.) and were used without further purification. With the
exception of TROMP358, PNOMP268, and PSOMP204,
these oligonucleotide primers hybridized to DNA sequences
of the MOMP gene of all chlamydial strains examined.
TROMP358 is specific for the trachoma group of chlamydial
MOMP genotypes, PNOMP268 is specific for the pneumonia
group, and PSOMP204 is specific for the polyarthritis group.
These primers were designed to match the known target
sequences of their cognate chlamydial group, but clustered
at the 3' ends they contain as many as eight nucleotides
which do not match the MOMP genes of the other chlamydial groups. When they were combined in one PCR with the

f:

v --

7

prim. genus
sec. genus

qr--

6

"a-q-2
452

V--

-

1120 bp
-

930 bp

sec. group

trachoma

pneumonia

990 bp
722 bp
536 bp

polyarthritis
FIG. 1. Schematic representation of the chlamydial MOMP gene indicating the relative positions of the oligonucleotide primers used in the
PCR amplifications. The translated regions are boxed; the leader peptide is darkly shadowed. Variable domains encoding antigenic
determinants are interspersed among highly conserved regions. Primers are drawn to scale only at the 3' ends. DNA fragments generated in
the PCR amplifications are indicated below the MOMP gene representation. Primers 1 and 2 (9CHOMP and CHOMP371) were used in
chlamydia genus-specific primary amplification (prim. genus); primers 3 and 4 (29CHOMP and CHOMP336) were used in genus-specific
secondary amplification (sec. genus). Primer 5 (TROMP358) is specific for the trachoma group of chlamydial MOMP genotypes, primer 6
(PNOMP268) is specific for the pneumonia group, and primer 7 (PSOMP204) is specific for the polyarthritis group. These primers were used
together with primer 3 (29CHOMP) in the secondary group-specific amplification (sec. group).
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MOMP genotypes were determined by Kaltenboeck et al. (12).
Serovars of C. psittaci were determined by Perez-Martinez and Storz (20); the serovar of C. trachomatis L2 was determined by Wang and Grayston (26).
'RFLP types were determined by Fukushi and Hirai (7).
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TABLE 2. Oligonucleotide primers used in primary and secondary PCR amplifications of chlamydial MOMP genes
Primer'

Sequence

9CHOMP
CHOMP371
29CHOMP
CHOMP336
TROMP358
PNOMP268
PSOMP204

5'-GCI(CT)TGCCTGTIGGGAA(CT)CCIGCIGA(AG)CC-3'
5'-TTAGAAIC(GT)GAATTGIGC(AG)TTIA(TC)GTGIGCIGC-3'

5'-GGIGA(CT)CCITG(CT)GA(CT)CCITG-3'
5'-CAAG(AC)TTTTCTGGA(CT)TT(AC)A(AT)(CT)TTGTT-3'
5'-G(AT)GTCTCAA(CT)(AT)GTAACTGC(AG)T-3'
5'-CCAATGTATGGCACTAAAGA-3'

5'-ACGTT(GT)A(AG)TTCTTGAACGCG-3'

Position"

64-92
+3-1177
133-152
1097-1072
1159-1139
887-868
695-676

genus-specific primer 29CHOMP, they generated DNA fragments of different lengths characteristic of their respective
chlamydial ompA target (Fig. 1).
PCR amplification. All PCRs were performed with 2.5 U of
Taq DNA polymerase (Gibco-Bethesda Research Laboratories, Gaithersburg, Md.) in 100-,u reactions containing 0.01%
bovine serum albumin and 0.1% Tween 20 in 20 mM Tris-HCl
(pH 8.3)-2.0 mM MgCI2-25 mM KCl-200 puM (each) deoxynucleoside triphosphates. Primers 9CHOMP and CHOMP371
were used at 0.2 p.M each in Chlamydia genus-specific
primary amplification; primers 29CHOMP and CHOMP336
were used in genus-specific secondary amplification. Primers
TROMP358, PNOMP268, and PSOMP204 were used together
with 29CHOMP at 0.1 p.M each in the secondary groupspecific amplification. To avoid PCR product carryover, positive displacement pipettes were used, and DNA was extracted and PCRs were assembled in two different
laboratories, which were strictly kept free of amplification
products. The samples were overlaid with mineral oil; and in
the primary amplification, they were subjected to 40 cycles of
1 s at 96°C, 30 s at 56°C, and 1 min at 72°C in a programmable
DNA thermal cycler (Eppendorf, Fremont, Calif.). Secondary amplifications were performed for 27 cycles of 1 s at 96°C,
30 s at 52°C, and 1 min at 72°C. After primary and secondary
PCRs, the samples were incubated at 72°C for 7 min. The
sensitivity of the PCR was established by using various
amounts of purified B577 DNA in a background of 1.0 p.g of
a mixture of uninfected L-cell and bacterial DNAs as input for
primary amplification. Amounts of 5 pI of amplified primary
reactions were used as input DNA in the secondary PCRs.
Two negative controls consisting of DNA extracted from
normal L cells and milk samples were included in all amplifications. A third control reaction contained only distilled
water (no DNA). PCR screening of samples was performed
by using 30 cycles for the PCRs and 10 p.l of 1:100 diluted
DNA (30 to 100 ng) extracted from infected yolk sacs or
purified chlamydial DNA. Subsequently, 5 p.1 of the 10-3_
diluted primary PCR products were used in the secondary
genus- and group-specific PCRs.
Analysis of amplified DNA. Amounts of 10 pul of the
amplified reaction were fractionated by 1.5% (1:1 ratio of
DNA-grade agarose to NuSieve agarose [FMC BioProducts,
Rockland, Maine]) or 4% (1:3 ratio of DNA-grade agarose to
NuSieve agarose) agarose gel electrophoresis directly or
after restriction endonuclease digestion, respectively. The
DNA was visualized by ethidium bromide staining and UV
fluorescence. The chlamydial MOMP genotypes were differentiated by restriction endonuclease analysis of the secondary amplification products. Genus-specific DNA fragments
of chlamydial MOMP genes of the psittacosis group and

group-specific MOMP gene fragments of the trachoma,
pneumonia, and polyarthritis groups were restricted. Appropriate restriction enzymes were identified by computer analysis of the partial MOMP gene DNA sequences (12). The
MOMP genotypes of these chlamydial groups were differentiated as ompA RFLP types with the following restriction
endonucleases: psittacosis with HaeIII, trachoma with
PvuII, pneumonia with Fnu4HI, and polyarthritis with
BstUI and BstYI. Ten to 20 p.1 of the secondary PCRs was
mixed with the appropriate buffer and restricted for 1 h at the
recommended temperature by using 10 U of the respective
enzymes (New England Biolabs, Beverly, Mass.). The specificity of the amplification was confirmed through (i) the
appearance of a single DNA fragment of the expected size
and (ii) the appearance of restriction patterns of the amplified
secondary DNA fragments as expected from the DNA
sequences of the partial MOMP genes.
Clinical samples. Seven milk samples were obtained from
cows suffering from chronic mastitis of variable severities.
These cows were randomly selected from different herds
surveyed in a mastitis control program. Low numbers of E.
coli were found in sample 2200 LR by standard bacteriological techniques; all other samples were free of detectable
bacteria. DNA was extracted as described earlier (13).
Samples of 10 p.l of DNA (0.2 to 0.7 pug) were subjected to
primary amplification, and subsequent procedures were performed as described above.
RESULTS
Determination of the sensitivity of genus-specific PCR amplification. The efficiency of PCR amplification was optimized in a series of experiments (11). Subsequently, the
sensitivities of primary and combined primary and secondary genus-specific amplifications were determined. The input
DNA consisted of 10-fold dilutions of purified B577 DNA in
a constant background of 1.0 ,ug of uninfected L-cell and
bacterial DNAs (which is the equivalent of 3 x 105 human
genomes or 3 x 108 E. coli genomes, respectively). The
number of chlamydial templates was calculated by assuming
that the MOMP gene is a single-copy gene (3) within the
1,450-kbp chlamydial genome (6) (1,563 ng of chlamydial
DNA equals 106 templates).
Chlamydial DNA representing 105 chlamydial genomes
(156.3 pg of DNA) yielded an expected single DNA fragment
of approximately 1,120 bp after primary amplification (Fig.
2). This fragment was clearly visible after ethidium bromide
staining. In contrast, DNA representing 104 chlamydial
genomes produced a 1,120-bp DNA fragment that stained
faintly in the original photograph but that was not intensive

Downloaded from https://journals.asm.org/journal/jcm on 20 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

a Primer designations: OMP, outer membrane protein gene; CH, Chlamydia spp.; TR, trachoma; PN, pneumonia; PS, psittacosis. The number in the primer
designation indicates the codon of C. psittaci MN (28) at the 3' end of the primer, and the position of the number to the left or right of the letters identifies sense
or antisense priming, respectively.
b
Position of the primer (5' to 3') on the MOMP gene of C. psittaci MN. +, 3-nontranslated regions of the MOMP gene.
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enough for visible reproduction in Fig. 2. A single DNA
fragment of the expected size of approximately 930 bp was
observed in the secondary amplification. Chlamydial DNA
representing three primary input genomes was sufficient for
visualization of the secondary 930-bp DNA fragment after
ethidium bromide staining.
Thus, combined primary and secondary genus-specific
amplifications are capable of detecting one cognate chlamydial genome in a 2.10 x 108-fold excess of unrelated DNA or
in a background of DNA derived from 105 human cells.
Genus-specific PCR amplification of chlamydial MOMP
gene fragments. To verify the spectrum of MOMP genes of
Chlamydia that can be amplified, we isolated DNA from
yolk sacs infected with strains with representative chlamydial MOMP genotypes. Diluted samples (1:100) were subjected to primary and secondary amplifications. The results
indicated that all chlamydial MOMP genes were amplified by
the genus-specific oligonucleotide primers (Fig. 3A and B).
Specific amplification of the chlamydial target DNA was
indicated by the presence of a single specific DNA fragment
in electrophoretic analysis of primary and secondary genusspecific PCRs. The slightly different migrations of DNA
fragments indicated size differences in the MOMP genes.
Thus, the two-step PCR of the chlamydial MOMP gene
with the primers 9CHOMP, CHOMP371, 29CHOMP, and
CHOMP336 amplifies DNA fragments from the known chlamydiae and might also detect as yet undefined chlamydial
variants.
Differentiation of groups of chlamydial MOMP genotypes
by PCR amplification. The secondary group-specific PCR
was developed as a tool for rapid preliminary classification
of chlamydial MOMP genotypes. The antisense, groupspecific primers TROMP358, PNOMP268, and PSOMP204
were designed to hybridize under stringent conditions with
different fingerprint regions of the MOMP genes of their
respective cognate groups but not with chlamydial MOMP
genes of the other groups. This resulted in a multiplex PCR
(4) in which the genus-specific sense primer 29CHOMP was
shared by all amplified DNA fragments (see Fig. 3C and 5C).
Chlamydiae of the trachoma, pneumonia, and polyarthritis
groups of MOMP genotypes yielded specific amplified DNA

;

B
sec.

group

-990 bp722 bp536 bpC

-

310 bp

FIG. 3. Determination of chlamydial MOMP genes of various
genotypes amplified in primary (A), secondary genus-specific (B),
and secondary group-specific (C) PCRs. DNA extracted from yolk
sacs infected with chlamydial strains with different MOMP genotypes or purified chlamydial DNA (AR388 and KOALA) was
subjected to primary and secondary amplifications. AR388 and
KOALA represent the pneumonia group; FEPN, GPIC, B577, and
BMZ1121 represent the psittacosis group; MOPN, L2, and S45
represent the trachoma group; and 66P130, LW613, L71, and 1710S
represent the polyarthritis group of MOMP genotypes. DNA fragments were resolved by 1.5% agarose gel electrophoresis and
ethidium bromide staining.

fragments of the expected lengths (Table 3). As anticipated,
MOMP genes of strains FEPN, GPIC, B577, and BMZ1121
of the psittacosis group could not be amplified. This group
was identified through positive amplification only in the
secondary genus-specific PCR.
The positive control sample (see left lane of Fig. 5C) was
the secondary group-specific amplification of a sample from
a primary PCR containing DNA of chlamydial MOMP genotypes represented by strains L2, AR388, and LW613. The
simultaneous appearance of DNA fragments specific for the
chlamydial groups trachoma, pneumonia, and polyarthritis
confirmed the potential of the secondary group-specific
amplification to identify multiple infections with certain
chlamydial MOMP genotypes.
Thus, in combination with genus-specific PCRs, the secondary group-specific amplification differentiated between
four groups of chlamydial MOMP genotypes. Furthermore,
it identified the simultaneous presence of chlamydial strains
of the trachoma, pneumonia, and polyarthritis groups.
Differentiation of chlamydial MOMP genotypes by restriction endonuclease analysis of amplified DNA fragments.
Knowledge of the partial MOMP gene DNA sequences of
the chlamydial MOMP genotypes listed in Tables 1 and 3
enabled us to further differentiate them as ompA RFLP types
by restriction endonuclease analysis of secondary groupspecific or genus-specific (psittacosis group) amplified DNA
fragments. Appropriate restriction endonucleases were rapidly identified by computer-assisted restriction mapping of
the partial MOMP genes. These enzymes and the expected
DNA fragment sizes after restriction are given in Table 3.
The differentiation scheme was designed such that closely
related MOMP genotypes represented by strains MN, 6BC,
and OA of the psittacosis group were recognized as restriction fragments of the same length representing the ompA

Downloaded from https://journals.asm.org/journal/jcm on 20 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

FIG. 2. Determination of the sensitivity of primary and combined primary and secondary genus-specific PCR amplifications of
the B577 MOMP gene. The indicated amounts of purified B577
template (temp.) DNA were mixed with 1.0 ig of background DNA
per 100-p.l reaction and were analyzed by PCR as described in the
text. DNA fragments were resolved by 1.5% agarose gel electrophoresis (1:1 ratio of DNA-grade agarose to NuSieve agarose) and
ethidium bromide staining. Primary amplification products can be
observed in the respective left lanes; secondary products can be
observed in the respective right lanes; negative (neg.) control
indicates background DNA without template. The molecular size
marker was 4X174RF DNA digested with HaeIII.

-1078 bp
- 872bp
- 603 bp
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TABLE 3. Calculated lengths of amplified and restricted MOMP gene DNA fragments of chlamydial strains included
in PCR detection and differentiationa
Length (bp)

Chlamydial
group

Chlamydial strain

Primary
genus-specific
PCR

genus-specific

Secondary

Secondary
group-specific
PCR

Secondary PCR restriction analysis

C. pneumoniae AR388

Pneumonia

1,104

923

722

576, 143, 3 (Fnu4HI)

C. psittaci
KOALA
FEPN
GPIC

Pneumonia
Psittacosis

923
935

722

362, 360 (Fnu4HI)
796, 88, 51 (HaeIII)

926
926
965

B577
BMZ1121

Psittacosis
Psittacosis

1,104
1,116
1,107
1,107
1,146

C. trachomatis
MOPN
L2
S45

Trachoma
Trachoma
Trachoma

1,101
1,122
1,119

920
941
938

1,002

66P130
LW613

Polyarthritis
Polyarthritis

1,116
1,110

935
929

536
536

L71
1710S

Polyarthritis
Polyarthritis

1,101
1,104

920
923

536
536

Psittacosis

395, 201, 197, 133 (HaeIII)
926 (HaeIII)
710, 255 (HaeIII)
981
999

614, 367 (PvuII)
565 437, (PvuII)
420, 379, 200 (PvuII)

C. psittaci

468, 37, 18, 13 (BstUI and BstYI)
294, 105, 69, 37, 18, 13 (BytUI and
BstYI)
294, 174, 37, 18, 13 (BstUI and BstYI)
399, 69, 37, 18, 13 (BstUI and BstYI)

RFLP type MN and types B577 and LW508 as another
identical ompA RFLP type B577 (12). Differentiation of the
trachoma group MOMP genotypes represented by strains
S45, MOPN, and L2 with PvuII is not comprehensive for all
human serovars of C. trachomatis and was intended to
merely discriminate between the given set of amplified
MOMP genotypes of the trachoma group.
Figure 4 demonstrates that cleavage with the respective
restriction endonucleases generated DNA fragments of the
expected size. Some fragments exhibited slightly aberrant
mobilities, such as the 395-bp DNA fragment of strain GPIC
ur4L-4HI
:D
8Z
LL
0-<< LL

Haelll

Pvull

BstUI&BstY

lXE
mN
M
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Cl

C

C

_

-

1078 Lip
8 72 bp;
6003 tn)

_ 3 10
-281. 271

I-

2

34 b

194 bp
11

I5

FIG. 4. Differentiation of ompA RFLP types by restriction endonuclease analysis of secondary amplification products. Ten to 20
±l1 of amplified secondary PCRs (genus specific for the psittacosis
group; group specific for the trachoma, pneumonia, and polyarthritis
groups) was mixed with restriction buffer and incubated with 10 U of
the indicated restriction endonucleases. DNA fragments were resolved by 4% agarose gel electrophoresis (1:3 ratio of DNA-grade
agarose to NuSieve agarose) and ethidium bromide staining.

(apparent mobility, approximately 360 bp) and, most notably, the 576-bp fragment of strain AR388, which migrated
with an apparent mobility of approximately 620 bp. These
aberrant mobilities were consistently found in analyses with
different agarose concentrations and electrophoresis buffers.
However, the original secondary DNA fragments of the
MOMP genes of the different genotypes represented by
these strains had the correct lengths (Fig. 3B and C), and
after restriction the remaining fragments of the original
amplified DNAs were identified at the correct positions.
These results indicate that restriction endonuclease analysis of secondary MOMP gene amplification products can
unambiguously achieve the intended differentiation of chlamydial ompA RFLP types.
PCR analysis of clinical samples. We analyzed the milk of
seven dairy cows suffering from mastitis to assess the
applicability of the established PCR amplification for detection of chlamydial MOMP gene sequences in clinical samples. Specific DNA fragments could not be visualized in the
primary amplification, indicating that there were a low
number of chlamydiae in the samples (Fig. 5). Secondary
genus-specific amplification yielded strongly staining, specific DNA fragments in samples 2200 LR and 2361 LF in
repeat examinations, while all other samples remained negative. Secondary group-specific amplifications were negative
in all samples, indicating that the MOMP gene fragments
amplified in the secondary genus-specific PCRs were derived
from the psittacosis group of chlamydial MOMP genotypes.
DNA fragments of these reactions were therefore analyzed
by restriction with HaeIII. The approximately 1,120-bp
fragments obtained after restriction indicated that the C.
psittaci-positive milk samples contained MOMP gene sequences of the ompA RFLP type B577.
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a
Oligonucleotide primers 9CHOMP and CHOMP371 were used in genus-specific primary amplification; 29CHOMP and CHOMP336 were used in
genus-specific secondary amplification. Primers 29CHOMP, TROMP358, PNOMP268, and PSOMP204 were used in secondary group-specific amplification. For
restriction endonuclease analysis, the amplified secondary group-specific PCR fragments of trachoma, pneumonia, and polyarthritis groups of MOMP genotypes
and secondary genus-specific PCR fragments of psittacosis group MOMP genotypes were digested with the indicated restriction enzymes. The DNA fragments
that were visible in agarose gels are indicated in boldface type. The fragment lengths were calculated by using published MOMP gene DNA sequences (1, 12, 24,
28) and additional unpublished data deposited in GenBank (accession codes M73033 to M73040, and M73042 to M73044).
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FIG. 5. PCR analysis of milk from seven cases of bovine mastitis. DNA extracted from milk samples were subjected to primary
(A), secondary genus-specific (B), and secondary group-specific (C)
amplifications. DNA fragments from secondary genus-specific PCRs
of samples 2361 LF and 2200 LR were analyzed by restriction with
HaeIII (D). The extraction control was performed with a mockextracted sample; the reagent control was a 100-plA PCR in the
absence of a DNA sample. DNA fragments were resolved by 1.5 or
4% agarose gel electrophoresis and ethidium bromide staining. PCR
products and HaeIII restriction products are indicated on the left
side of the respective panels. A secondary group-specific PCR is
included as a positive control in the leftmost lane of panel C. The
primary input sample of this PCR contained DNA of chlamydial
MOMP genes of genotypes L2 (trachoma group), AR388 (pneumonia group), and LW613 (polyarthritis group).

These results demonstrate that the Chlamydia genusspecific PCR amplification can be successfully applied to
clinical samples and that the ompA RFLP type contained in
positive samples can be determined by restriction endonuclease analysis of secondary amplification products.
DISCUSSION
A two-step PCR amplification procedure with a nested set
of degenerate oligonucleotide primers specific for the
MOMP gene of the genus Chlamydia was developed. This
method can detect and differentiate chlamydial MOMP gene
DNA fragments by a combination of group-specific amplification and RFLP analysis. The detection limit of this method
approached three chlamydial templates in the presence of 1
,ug of eucaryotic and bacterial background DNAs. We
performed 27 secondary PCR cycles, resulting in a sensitivity limit of three chlamydial templates, because, occasionally, the negative control reactions became weakly positive
when additional cycles of secondary amplification were
used. Thus, the two-step PCR amplification procedure offers
the advantage that the sensitivity of the system can easily be
adjusted.
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The absolute detection limit of this method is given by the
ratio of chlamydial target DNA to background DNA. The
minimal ratio is one target molecule per approximately 1 ,ug
of DNA in a 100-,ul PCR. At background DNA levels above
1 ,ug.per 100-,ul PCR, unspecific amplification dramatically
increases while the efficiency of the specific amplification is
reduced. Consequently, the sensitivity of chlamydial detection can be further improved only by minimizing the amount
of background DNA. This can be achieved by differential
sedimentation of cellular nuclei after sonication of a sample.
Assuming a Poisson distribution in DNA samples, falsenegative results are predicted to appear with low amounts of
chlamydial DNA. Analysis of multiple samples are necessary to confirm truly negative reactions.
An important advantage of the two-step PCR detection
procedure with two nested pairs of unrelated primers is its
high specificity (16). This method requires only minimal
laboratory equipment for amplification and detection of the
amplified DNA fragments. It can be performed in 1 workday
without additional detection techniques, such as Southern
hybridization or enzyme-linked immunosorbent assay-based
hybrid capture assays (2).
We designed the genus-specific primers 9CHOMP,
CHOMP371, 29CHOMP, and CHOMP336 from highly conserved DNA sequences of the 5' and 3' ends of the translated
ompA regions for recognition of the broadest possible spectrum of chlamydial MOMP genes. The chlamydial strains
analyzed in this investigation constitute a comprehensive set
of chlamydial variants. These primers matched the DNA
sequences of genes of MOMP genotypes not examined in
this study (those of strains 6BC, OA, LW508) and some
serovars of C. trachomatis except L2. The complete MOMP
gene DNA sequences of C. trachomatis serovars Ba, D, G,
I, J, K, and L3 have not been determined. The cognate
regions of the primers at the 5' and 3' ends of the MOMP
gene are the most highly conserved ompA sequences. It is
expected that these primers will hybridize and amplify these
genes.
The secondary group-specific amplification facilitated
rapid identification of the overall position within the chlamydial phylogeny of an amplified MOMP gene DNA fragment. It was also capable of detecting mixed infections with
chlamydial strains of the trachoma, pneumonia, and polyarthritis groups. The sensitivity of this amplification varied
slightly, depending on the length of the amplified groupspecific DNA fragment, but it could be adjusted like the
secondary genus-specific amplification could.
Further differentiation of amplified products can be
achieved by RFLP analysis. The availability of MOMP gene
DNA sequences allows an appropriate selection of restriction endonucleases for RFLP analysis.
While the RFLP analysis of the psittacosis, polyarthritis,
and pneumonia groups differentiated a spectrum of MOMP
genotypes, the analysis of the trachoma group was not
comprehensive. The complete MOMP gene DNA sequences
of C. trachomatis serovars Ba, D, G, I, J, K, and L3 are
needed for complete RFLP typing of the trachoma group.
The detection of MOMP gene DNA sequences in two of
seven milk samples from cases of bovine mastitis and the
subsequent differentiation of the secondary genus-specific
DNA fragments by HaeIII restriction enzyme analysis demonstrate the feasibility of PCR-based detection and differentiation of chlamydiae in clinical samples. It will be necessary
to optimize the extraction of DNA from the sample and the
handling of large numbers of samples for PCR detection of
chlamydiae in the clinical setting.
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The data presented in this report indicate that the MOMP
gene of extant variants of the genus Chlamydia can be
detected by a two-step PCR. Amplified DNA fragments can
be easily differentiated by group-specific secondary amplification and RFLP analysis. This differentiation combined
with rapid DNA sequencing of secondary genus-specific
amplification products (12, 15) could lead to the identification of as yet undefined chlamydial variants. Unlike chlamydial infections in humans, the diseases caused by chlamydiae in animals are not widely recognized. We anticipate
that PCR-based genus-specific detection and differentiation
of Chlamydia spp. will contribute to understanding of the
epidemiology and pathogenesis of chlamydial infections.
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